Gm24508 Gene Detail

Summary

• Symbol
  Gm24508
• Name
  predicted gene, 24508

• Feature Type
  snRNA gene
• IDs
  MGI:5454285
  NCBI Gene: 115488733
• Alliance
  gene page

Location &
Maps

• Sequence Map
  Chr16:84091423-84091529 bp, + strand

  From NCBI annotation of GRCm39
  

• View this region in JBrowse
  

• Genome Browsers
  Ensembl | UCSC | NCBI

• Genetic Map
  Chromosome 16, Syntenic
• Mapping Data
  1 experiment

Strain
Comparison

• SNPs within 2kb
  146 from dbSNP Build 142
• Strain Annotations
  1

Strain	Gene Model ID	Feature Type	Coordinates
C57BL/6J	MGI_C57BL6J_5454285	snRNA gene	Chr16:84091423-84091529 (+)
129S1/SvImJ	no annotation
A/J	no annotation
AKR/J	no annotation
BALB/cJ	no annotation
C3H/HeJ	no annotation
C57BL/6NJ	no annotation
CAROLI/EiJ	no annotation
CAST/EiJ	no annotation
CBA/J	no annotation
DBA/2J	no annotation
FVB/NJ	no annotation
LP/J	no annotation
NOD/ShiLtJ	no annotation
NZO/HlLtJ	no annotation
PWK/PhJ	no annotation
SPRET/EiJ	no annotation
WSB/EiJ	no annotation

Homology

• Gene Tree
  Gm24508
  

Human Diseases

• References
  7 with disease annotations

Mutations,
Alleles, and
Phenotypes

• Phenotype Summary
  354 phenotype references
  

• All Mutations and Alleles
  5
• Radiation induced
  1
• Targeted
  3
• Genomic Mutations
  5 involving Gm24508
• Find Mice (IMSR)
  0 strains or lines available

Sequences &
Gene Models

• All Sequences
  5
• RefSeq
  1

• Ensembl
  ENSMUSG00000119180 (Evidence)
• NCBI Gene
  115488733

Representative Sequences			Length	Strain/Species
genomic	115488733	NCBI Gene Model | MGI Sequence Detail	107	C57BL/6J
transcript	XR_004939430	RefSeq | MGI Sequence Detail	107	C57BL/6J

References

• Summaries
  All 357

  Diseases 7

  Phenotypes 354
• Earliest
  J:30229 Davisson MT, et al., Segmental trisomy as a mouse model for Down syndrome. Prog Clin Biol Res. 1993;384:117-33
• Latest
  J:354984 Emili M, et al., Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model. Neuropharmacology. 2024 Sep 27;261:110170